Back to search
RDS of Prematurity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which RDS of Prematurity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which RDS of Prematurity trials you may qualify forRespiratory distress syndrome (RDS) is a common cause of respiratory failure in preterm infants and is frequently treated with surfactant therapy. With the incr…
The primary objective of this study is to compare work of breathing indices before and after extubation in intubated premature infants admitted to the Christian…
Being born too early (preterm birth) is the leading cause of death in children world-wide. In Australia, 97% of very preterm babies who are admitted to Neonatal…
This is a 2-part, prospective, randomized, blinded, sham-controlled, multi-center study comparing preterm subjects with RDS who are treated with APC-0101 and nC…
This prospective, non-randomized, unblinded pilot study evaluates and compares the intrapulmonary distribution of exogenous surfactant in preterm neonates when…
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm i…
The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffe…
Evidence suggests that increased intravascular and interstitial fluid load in neonates with transient tachypnea of the newborn (TTN) may delay the clearance of…
The goal of this observational study is to evaluate different methods of surfactant administration in preterm infants with respiratory distress syndrome (RDS).…